Champion™ pET100 Directional TOPO™ Expression Kit with BL21 Star™ (DE3) One Shot™ Chemically Competent E. coli
본 제품은 LMO 제품으로, 고객 분께서 LMO 신고 시스템을 통해 직접 수입 신고를 진행해주셔야 합니다. 자세히보기
Product Image
Invitrogen™

Champion™ pET100 Directional TOPO™ Expression Kit with BL21 Star™ (DE3) One Shot™ Chemically Competent E. coli

Champion™ pET Expression System은 E. coli에서 최고 수준의 단백질 수율을 제공합니다. 발현 중 관심 단백질이 총 세포 단백질의 50% 이상에자세히 알아보기
Have Questions?
카탈로그 번호수량
K1000120 reactions
카탈로그 번호 K10001
제품 가격(KRW)
1,383,000
온라인 행사
Ends: 31-Mar-2026
1,626,000
할인액 243,000 (15%)
Each
카트에 추가하기
수량:
20 reactions
제품 가격(KRW)
1,383,000
온라인 행사
Ends: 31-Mar-2026
1,626,000
할인액 243,000 (15%)
Each
카트에 추가하기
Champion™ pET Expression System은 E. coli에서 최고 수준의 단백질 수율을 제공합니다. 발현 중 관심 단백질이 총 세포 단백질의 50% 이상에 달할 수 있습니다. 원래 Studier 연구진(1-3)이 개발한 T7 발현 벡터를 기반으로 T7 RNA 중합효소가 native E. coli RNA 중합효소보다 진화되어 있고 관심 유전자 transcription에 맞게 만들어졌기 때문에 높은 수준의 발현이 달성됩니다. mRNA transcript의 안정성을 크게 개선하고 단백질 발현을 10배까지 높이는 발현 균주 BL21 Star™ E. coli로 이 시스템에서 단백질 생산이 더욱 증강됩니다.

간편하고 효율적인 Directional TOPO™ 클로닝으로
Champion™ pET 발현 벡터에 빠르게 들어갈 수 있습니다. 이들 키트는 5분 직접 클로닝을 위한 선형 topoisomerase I-activated Champion™ pET 발현 벡터를 가지고 있습니다. Directional TOPO™ Cloning 기술은 다음과 같은 이유로 유전자 발현을 촉진합니다.

• PCR에 확인 효소를 사용하여 클론 유전자의 오류를 줄입니다.

• 클론의 90% 이상이 유전자 발현에 맞는 방향으로 군집 스크리닝을 위한 시간이 단축됩니다.

7가지 Champion™ pET Directional TOPO™ Expression Vectors를 이용할 수 있습니다(그림 1 및 표 1): 각 벡터에는 고수준 발현을 위해 T7lac 촉진자가 들어있습니다. 단백질 검출 간편화, 정제 태그 제거, plasmid 운반 클론의 선택 및/또는 단백질 수율 개선을 위한 융통성 있는 옵션을 이용할 수 있습니다.
Champion™ pET Directional TOPO™ 벡터를 사용하면 최고의 단백질 수율을 기대할 수 있습니다. 그림 2는 Champion™ pET Directional TOPO™ 벡터에서 lacZ 유전자의 발현을 나타냅니다. 그림 3은 pET151/D-TOPO™에서 발현되는 β-galactosidase 융합 단백질의 N 말단 태그의 TEV protease 를 사용한 효율적인 절단을 보여줍니다
For Research Use Only. Not for use in diagnostic procedures.
사양
항생제 내성 박테리아Ampicillin (AmpR)
박테리아 또는 효모 균주BL21 Star™(DE3)
분열EK (Enterokinase) Recognition Site
구성 또는 유도성 시스템Inducible
발현 메커니즘Cell-Based Expression
발현 시스템E. coli
유도제IPTG
제품 유형TOPO Expression Kit
수량20 reactions
선택 제제(진핵)None
벡터pET
클로닝 방법Directional TOPO
제품라인One Shot
프로모터T7, lacO
단백질 태그His Tag (6x), Xpress Epitope Tag
Unit SizeEach
구성 및 보관
Each Champion™ pET Directional TOPO™ Expression Kit is provided as a complete expression system. The Directional TOPO™ Expression box contains 200 ng of linearized, topoisomerase I-activated Champion™ pET vector; sterile water; dNTPs; 10X PCR Buffer; salt solution; control template and primers; primers for sequencing or PCR screening; and an expression control. Store at -20°C. The One Shot™ TOP10 box contains twenty-one 50-μl aliquots of chemically competent E. coli, S.O.C. medium, and a control plasmid. Store at -80°C. The One Shot™ BL21 Star™(DE3) box contains twenty-one 50-μl aliquots of chemically competent E. coli, S.O.C. medium, and a control plasmid. Store at -80°C. Kits with Lumio™ Technology include 20 μl of the Lumio™ Detection Reagent. Store at -20°C. Guaranteed stable for 6 months when properly stored.

자주 묻는 질문(FAQ)

My gene of interest is toxic to bacterial cells. Are there any precautions you can suggest?

Several precautions may be taken to prevent problems resulting from basal level expression of a toxic gene of interest. These methods all assume that the T7-based or Champion-based expression plasmid has been correctly designed and created.

- Propagate and maintain your expression plasmid in a strain that does not contain T7 RNA polymerase (i.e., DH5α).
- If using BL21 (DE3) cells, try growing cells at room temperature rather than 37 degrees C for 24-48 hr.
- Perform a fresh transformation using a tightly regulated E. coli strain, such as BL21-AI cells.
- After following the transformation protocol, plate the transformation reaction on LB plates containing 100 µg/mL ampicillin and 0.1% glucose. The presence of glucose represses basal expression of T7 RNA polymerase.
- Following transformation of BL21-AI cells, pick 3 or 4 transformants and inoculate directly into fresh LB medium containing 100 µg/mL ampicillin or 50 µg/mL carbenicillin (and 0.1% glucose, if desired). When the culture reaches an OD600 of 0.4, induce expression of the recombinant protein by adding L-arabinose to a final concentration of 0.2%.
- When performing expression experiments, supplement the growth medium with 0.1% glucose in addition to 0.2% arabinose.
- Try a regulated bacterial expression system such as our pBAD system.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm trying to express my protein using a bacterial expression system. How do I know if I'm seeing degradation of my protein or if what I’m seeing is codon usage bias?

Typically, if you see 1-2 dominant bands, translation stopped prematurely due to codon usage bias. With degradation, you usually see a ladder of bands. With degradation, you can try using a protease inhibitor and add it to the lysis buffer to help prevent degradation. If degradation is the issue, a time point experiment can be done to determine the best time to harvest the cells.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm trying to express my protein using a bacterial expression system and am getting inclusion bodies. What should I do?

If you are having a solubility issue, try to decrease the temperature or decrease the amount of IPTG used for induction. You can also try a different, more stringent cell strain for expression. Adding 1% glucose to the bacterial culture medium during expression can also help.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm getting low protein yield from my bacterial expression system. What can I do to improve this?

- Inoculate from fresh bacterial cultures, since higher protein yields are generally obtained from a fresh bacterial colony.

- Check the codon usage in the recombinant protein sequence for infrequently used codons. Replacing the rare codons with more commonly used codons can significantly increase expression levels. For example, the arginine codons AGG and AGA are used infrequently by E. coli, so the level of tRNAs for these codons is low.

- Add protease inhibitors, such as PMSF, to buffers during protein purification. Use freshly made PMSF, since PMSF loses effectiveness within 30 min of dilution into an aqueous solution.

- If you are using ampicillin for selection in your expression experiments, you may be experiencing plasmid instability due to the absence of selective conditions. This occurs as the ampicillin is destroyed by β-lactamase or hydrolyzed under the acidic media conditions generated by bacterial metabolism. You may want to substitute carbenicillin for ampicillin in your transformation and expression experiments.

- The recombinant protein may be toxic to bacterial cells. Try a tighter regulation system for competent cell expression such as BL21-AI. You may also consider trying a different expression system such as the pBAD system.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

My cells are growing very slowly, and I'm not getting any protein expression from my baterial expression system. What can I do to fix this?

This typically occurs when your gene of interest is toxic. Try using a tighter regulation system, such as BL21 (DE3) (pLysS) or BL21 (DE3) (pLysE), or BL21(AI).

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

인용 및 참조 문헌 (14)

인용 및 참조 문헌
Abstract
The protein phosphatases of Synechocystis sp. strain PCC 6803: open reading frames sll1033 and sll1387 encode enzymes that exhibit both protein-serine and protein-tyrosine phosphatase activity in vitro.
Authors:Li R,Potters MB,Shi L,Kennelly PJ
Journal:Journal of bacteriology
PubMed ID:16109928
The open reading frames (ORFs) encoding two potential protein-serine/threonine phosphatases from the cyanobacterium Synechocystis sp. strain PCC 6803 were cloned and their protein products expressed in Escherichia coli cells. The product of ORF sll1033, SynPPM3, is a homologue of the PPM family of protein-serine/threonine phosphatases found in all eukaryotes as ... More
A TFIIB-like protein is indispensable for spliced leader RNA gene transcription in Trypanosoma brucei.
Authors:Schimanski B, Brandenburg J, Nguyen TN, Caimano MJ, Günzl A,
Journal:Nucleic Acids Res
PubMed ID:16554554
'The lack of general class II transcription factors was a hallmark of the genomic sequences of the human parasites Trypanosoma brucei, Trypanosoma cruzi and Leishmania major. However, the recent identification of TFIIA as part of a protein complex essential for RNA polymerase II-mediated transcription of SLRNA genes, which encode the ... More
A GPI-linked carbonic anhydrase expressed in the larval mosquito midgut.
Authors:Seron TJ, Hill J, Linser PJ,
Journal:J Exp Biol
PubMed ID:15579552
'We have previously described the first cloning and partial characterization of carbonic anhydrase from larval Aedes aegypti mosquitoes. Larval mosquitoes utilize an alkaline digestive environment in the lumen of their anterior midgut, and we have also demonstrated a critical link between alkalization of the gut and carbonic anhydrase(s). In this ... More
Biophysical characterization of the interaction domains and mapping of the contact residues in the XPF-ERCC1 complex.
Authors:Choi YJ, Ryu KS, Ko YM, Chae YK, Pelton JG, Wemmer DE, Choi BS,
Journal:J Biol Chem
PubMed ID:15932882
'XPF and ERCC1 exist as a heterodimer to be stable and active in cells andatalyze DNA cleavage on the 5''-side of a lesion during nucleotide excision repair. To characterize the specific interaction between XPF and ERCC1, we expressed the human ERCC1 binding domain of XPF (XPF-EB) and the XPF binding ... More
ADAMTS13 substrate recognition of von Willebrand factor A2 domain.
Authors:Zanardelli S, Crawley JT, Chion CK, Lam JK, Preston RJ, Lane DA,
Journal:J Biol Chem
PubMed ID:16221672
'ADAMTS13 controls the multimeric size of circulating von Willebrand factor (VWF) by cleaving the Tyr1605-Met1606 bond in theA2 domain. To examine substrate recognition, we expressed in bacteria and purified three A2 (VWF76-(1593-1668), VWF115-(1554-1668), VWFA2-(1473-1668)) and one A2-A3 (VWF115-A3-(1554-1874)) domain fragments. Using high pressure liquid chromatography analysis, the initial rates of ... More